TickerFactsScreenerDevelopers

Amneal Pharmaceuticals, Inc. (AMRX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2016: $122.76M2017: $94.77M2018: $83.09M2019: $47.18M2020: $56.45M2021: $47.73M2022: $46.41M2023: $43.22M2024: $51.92M2025: $70.06M$70.06M
2016Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$70.06M+34.9%
2024$51.92M+20.1%
2023$43.22M-6.9%
2022$46.41M-2.8%
2021$47.73M-15.4%
2020$56.45M+19.6%
2019$47.18M-43.2%
2018$83.09M-12.3%
2017$94.77M-22.8%
2016$122.76M—